Outcomes of severe pre‐eclampsia/eclampsia in Yorkshire 1999/2003
Open Access
- 17 May 2005
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 112 (7) , 875-880
- https://doi.org/10.1111/j.1471-0528.2005.00565.x
Abstract
Objective To establish the risk of serious complications from severe pre‐eclampsia and eclampsia in a region using a common guideline for the management of these conditions. Design A five‐year prospective study. Setting Sixteen maternity units in Yorkshire. Population All women managed with severe pre‐eclampsia and eclampsia. Methods A common guideline was developed for the management of women with these conditions. A network of midwives prospectively collected outcome data. Main outcome measure Incidence of the conditions and serious complication rates. Results A total of 210,631 women delivered in the 16 units between 1 January 1999 and 31 December 2003. One thousand eighty‐seven women were diagnosed with severe pre‐eclampsia or eclampsia (5.2/1000). One hundred and fifty‐one women had serious complications including 82 women (39/10,000) having eclamptic seizures and 49 women (23/10,000) requiring ICU admission. There were no maternal deaths but 54 out of 1145 babies died before discharge, giving a mortality rate of 47.2/1000. Of the 82 cases of eclampsia, 45 occurred antenatally (55%), 18 before admission to the maternity unit. Eleven cases occurred in labour (13%), including 1 during a caesarean section, and 26 cases occurred following delivery (32%). Twenty‐five women developed pulmonary oedema (2.3% of cases) and six women required renal dialysis (0.55% of cases). One hundred and sixty‐five (15%) required no antihypertensive therapy and 489 (53%) of the remainder required only oral therapy. Two hundred and one (18.5%) required more than one drug. Conclusion A regional guideline for severe pre‐eclampsia and eclampsia can be developed and implemented. Its use may contribute to a low rate of serious complications.Keywords
This publication has 14 references indexed in Scilit:
- Managing pre-eclampsia 1: establishing guidelinesBritish Journal of Midwifery, 2004
- Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trialThe Lancet, 2002
- Intensive Care Utilization during Hospital Admission for DeliveryAnesthesiology, 2000
- Early risk assessment of severe preeclampsia: Admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidityAmerican Journal of Obstetrics and Gynecology, 1999
- Does labetalol predispose to pulmonary edema in severe pregnancy-induced hypertensive disease?The Journal of Maternal-Fetal Medicine, 1998
- Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from termEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1995
- Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia TrialThe Lancet, 1995
- Eclampsia in the United KingdomBMJ, 1994
- Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)American Journal of Obstetrics and Gynecology, 1993
- Eclampsia in the United Kingdom. The 'BEST' way forwardBJOG: An International Journal of Obstetrics and Gynaecology, 1992